Trubion Pharmaceuticals Inc. (TRBN) CEO Retires
11/17/2009 10:42:31 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Announces Acceptance of Two Presentations on Its TRU-016 Product Candidate at the 2009 American Society of Hematology Annual Meeting
11/12/2009 8:03:28 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Reports Third Quarter and Nine Months 2009 Financial Results
11/6/2009 9:54:24 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Announces Dates for Third Quarter and Nine Months 2009 Earnings Conference Call
10/30/2009 10:37:46 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Announces Upcoming Presentation at 8th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/27/2009 8:44:21 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) to Present at the Morgan Stanley Global Healthcare Conference
9/9/2009 8:45:19 AM
More...
|
Facet Biotech and Trubion Pharmaceuticals Inc. (TRBN) Announce Worldwide Collaboration for the Development and Commercialization of TRU-016 in Deal Worth up to $196.5 Million
8/28/2009 6:33:26 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Reports Second Quarter and First Half 2009 Financial Results
8/7/2009 10:31:03 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Announces Dates for Second Quarter and First Half 2009 Earnings Conference Call
7/31/2009 9:48:51 AM
More...
|
Trubion Pharmaceuticals Inc. (TRBN) Announces Extension of Research Period Under Its Wyeth (WYE) Collaboration
6/23/2009 7:49:44 AM
More...
|
|